﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Generated by www.ashp.org on Tue, 09 Feb 2010 10:24:09--><rss version="2.0"><channel><title>ASHP Health-System Pharmacy News</title><link>http://www.ashp.org/Import/NEWS/HealthSystemPharmacyNews.aspx</link><description>ASHP Health-System Pharmacy News</description><language>en-us</language><copyright>Copyright2010 ASHP</copyright><docs>http://blogs.law.harvard.edu/tech/rss/</docs><lastBuildDate>Tue, 09 Feb 2010 10:24:09</lastBuildDate><image><url>http://www.ashp.org/images/ashprss.gif</url><title>ASHP</title><link>http://www.ashp.org/</link><width>57</width><height>34</height></image><item><title><![CDATA[Sanofi Recalls Subpotent H1N1 Vaccine]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3268</link><description><![CDATA[Six&#160;lots of Sanofi's monovalent H1N1 influenza vaccine have been recalled due to diminished potency, according to an announcement from the Centers for Disease Control and Prevention's (CDC's) Health Alert Network.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3268</guid><pubDate>Wed, 03 Feb 2010</pubDate></item><item><title><![CDATA[Enzyme Product Approved for Rare Hand Disorder]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3267</link><description><![CDATA[FDA and Auxilium Pharmaceuticals announced the licensing of collagenase clostridium histolyticum, or Xiaflex for injection, for the treatment of Dupuytren's contracture in adults.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3267</guid><pubDate>Wed, 03 Feb 2010</pubDate></item><item><title><![CDATA[Pharmacist's Out-of-the-Box Thinking Helps Haitian Earthquake Victims]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3266</link><description><![CDATA[Emergency department pharmacist Shannon Manzi said she often finds a creative way to make a drug delivery device designed for adults suitable for the patients she sees at Children's Hospital Boston. That type of out-of-the-box thinking by Manzi helped hundreds of Haitians who sought medical attention in the first two weeks after the 7.0-magnitude earthquake struck on January 12.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3266</guid><pubDate>Mon, 01 Feb 2010</pubDate></item><item><title><![CDATA[Warning About Severe Liver Complications Added to Didanosine Labeling]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3265</link><description><![CDATA[A notice from FDA dated January 29 warns clinicians about a rare but potentially deadly adverse hepatic event affecting patients who take the antiretroviral drug didanosine.]]></description><category>ASHP Action Line</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3265</guid><pubDate>Mon, 01 Feb 2010</pubDate></item><item><title><![CDATA[New Drug and Biological Product Approvals, 2009]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3264</link><description><![CDATA[Thirty-seven new molecular entities, vaccines, and blood products won FDA marketing approval last year, up from 34 in the previous year. Highlights of the approved products appear below, and a full list of new products and their indications appears below.]]></description><category>AJHP</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3264</guid><pubDate>Fri, 29 Jan 2010</pubDate></item><item><title><![CDATA[EPA Eyes Unused Pharmaceuticals]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3263</link><description><![CDATA[Health care facilities can expect the Environmental Protection Agency (EPA) by October to release a set of best practices for managing excess, expired, and unwanted pharmaceuticals.]]></description><category>AJHP</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3263</guid><pubDate>Thu, 28 Jan 2010</pubDate></item><item><title><![CDATA[Decrease Velcade Starting Dosage in Patients With Liver Disease]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3262</link><description><![CDATA[FDA on Tuesday announced revisions to the labeling of bortezomib, including a change in the recommended starting dosage for some patients with liver disease.]]></description><category>ASHP Action Line</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3262</guid><pubDate>Wed, 27 Jan 2010</pubDate></item><item><title><![CDATA[Liraglutide Approved To Help Treat Type 2 Diabetes]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3261</link><description><![CDATA[Novo Nordisk and FDA on January 25 announced the approval of liraglutide, or Victoza, an injectable glucagon-like peptide-1-receptor agonist that can help adults with type 2 diabetes mellitus improve glycemic control.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3261</guid><pubDate>Tue, 26 Jan 2010</pubDate></item><item><title><![CDATA[FDA Approves First Morphine Sulfate Concentrate]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3260</link><description><![CDATA[Although morphine sulfate 20-mg/mL oral solutions have been available for awhile, patients in moderate to severe pain who are opioid tolerant now have access to a morphine concentrate whose manufacturing controls, safety, and efficacy meet the standards of FDA, the agency announced today.]]></description><category>ASHPNews</category><author>Cheryl A. Thompson</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3260</guid><pubDate>Tue, 26 Jan 2010</pubDate></item><item><title><![CDATA[Two Million Nipro Infusion Sets Recalled]]></title><link>http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3259</link><description><![CDATA[More than 2 million infusion sets manufactured by Nipro Medical Corporation have been recalled over concerns that cores from silicone access ports can be drawn into the needles as they are used to deliver chemotherapy and other medications, FDA announced today.]]></description><category>ASHPNews</category><author>Kate Traynor</author><guid isPermaLink="false">http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=3259</guid><pubDate>Tue, 26 Jan 2010</pubDate></item></channel></rss>